Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data

被引:88
作者
Gu, CH [1 ]
Grant, DJW [1 ]
机构
[1] Univ Minnesota, Coll Pharm, Dept Pharmaceut, Minneapolis, MN 55455 USA
关键词
enantiotrope; enthalpy of solution; hydrate; monotrope; polymorph; solubility; sulfamerazine; transition temperature;
D O I
10.1002/jps.1080
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The transition temperature, Tt, of polymorphs is estimated from both their heats of solution and solubilities (or intrinsic dissolution rates) determined at any one temperature (e.g., ambient). At a given temperature, T, the enthalpy difference, DeltaH, between polymorphs, I and II, is equal to the difference between their heats of solution, whereas the free energy difference, AG, can be estimated by the equation, DeltaG = -RTln (c(I)/c(II)) or DeltaG = -RTln (J(I)/J(II)), where c is the solubility and J is the intrinsic dissolution rate. The entropy difference, DeltaS, is evaluated as (DeltaH - DeltaG)/T. Because the heat capacity difference, DeltaC(t) between polymorphs is small enough to be neglected, the transition temperature may be estimated by the equation, T-t=DeltaH/DeltaS. The thermodynamic stability relationships of the polymorphs (i.e., whether they are enantiotropes or monotropes) are predicted from the value of T-t and the melting temperature. The T-t values for auranofin, carbamazepine, chloramphenicol palmitate, cyclopenthiazide, gepirone hydrochloride, lamivudine, MK571, premafloxacin, sulfamerazine, sulfamethoxazole, sulfathiazole, and urapidil, were calculated from reported values of the heats of solution and solubilities (or dissolution rates). The stability relationships deduced from the calculated values of Tt are in good agreement with those reported using other methods, such as differential scanning calorimetry and interpretation of melting data. (C) 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association.
引用
收藏
页码:1277 / 1287
页数:11
相关论文
共 33 条
[1]  
ACHARYA KR, 1982, J CRYST SPECTROSC, V12, P369
[2]   HEAT OF FUSION MEASUREMENT OF A LOW MELTING POLYMORPH OF CARBAMAZEPINE THAT UNDERGOES MULTIPLE-PHASE CHANGES DURING DIFFERENTIAL SCANNING CALORIMETRY ANALYSIS [J].
BEHME, RJ ;
BROOKE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) :986-990
[3]   CHARACTERIZATION OF POLYMORPHISM OF GEPIRONE HYDROCHLORIDE [J].
BEHME, RJ ;
BROOKE, D ;
FARNEY, RF ;
KENSLER, TT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (10) :1041-1046
[4]   PHYSICAL CHARACTERIZATION OF SOLID FORMS OF URAPIDIL [J].
BOTHA, SA ;
GUILLORY, JK ;
LOTTER, AP .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1986, 4 (05) :573-587
[5]   POLYMORPHISM OF PHARMACEUTICALS AND OTHER MOLECULAR-CRYSTALS .1. THEORY OF THERMODYNAMIC RULES [J].
BURGER, A ;
RAMBERGER, R .
MIKROCHIMICA ACTA, 1979, 2 (3-4) :259-271
[6]  
BURGER A, 1991, EUR J PHARM BIOPHARM, V37, P118
[7]   CRYSTAL DEFECTS AND DISSOLUTION [J].
BURT, HM ;
MITCHELL, AG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1981, 9 (02) :137-152
[8]  
CAIRA MR, 1992, ACTA CRYSTALLOGR B, V48, P492
[9]   POLYMORPHIC STATUS OF SORBITOL - SOLUTION CALORIMETRY VERSUS DSC [J].
CAMMENGA, HK ;
STEPPUHN, ID .
THERMOCHIMICA ACTA, 1993, 229 :253-256
[10]  
Chen L R, 1998, Pharm Dev Technol, V3, P487, DOI 10.3109/10837459809028630